{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T09:28:53Z","timestamp":1787045333279,"version":"build-2736575974"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:00:00Z","timestamp":1787011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:00:00Z","timestamp":1787011200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hematopathol"],"DOI":"10.1007\/s12308-026-00723-4","type":"journal-article","created":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T08:47:31Z","timestamp":1787042851000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Erythroblastic sarcoma with biallelic TP53 mutations and novel NUP214:: ABL1\u2014new finding in erythroblastic sarcoma\/acute erythroid leukemia"],"prefix":"10.1007","volume":"19","author":[{"given":"Rebecca","family":"Manzo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changqing","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenya","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph D.","family":"Khoury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-2008-1496","authenticated-orcid":false,"given":"Shanxiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,18]]},"reference":[{"key":"723_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.modpat.2025.100716","volume":"38","author":"MJ Fitzpatrick","year":"2025","unstructured":"Fitzpatrick MJ, Yuan J, Capa I et al (2025) Erythroblastic sarcoma in adults and children: different pathways to the same destination. Mod Pathol 38:100716","journal-title":"Mod Pathol"},{"key":"723_CR2","first-page":"312","volume":"53","author":"TI George","year":"2021","unstructured":"George TI, Bajel A (2021) Diagnosis of rare subtypes of acute myeloid leukaemia and related neoplasms. Pathology (Phila) 53:312\u2013327","journal-title":"Pathology (Phila)"},{"key":"723_CR3","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1002\/pbc.25898","volume":"63","author":"R Lapadat","year":"2016","unstructured":"Lapadat R, Tower RL 2nd, Tam W et al (2016) Pure erythroid leukemia mimicking Ewing sarcoma\/primitive neuroectodermal tumor in an infant. Pediatr Blood Cancer 63:935\u2013937","journal-title":"Pediatr Blood Cancer"},{"key":"723_CR4","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.31848","volume":"72","author":"AL Chang-Graham","year":"2025","unstructured":"Chang-Graham AL, Nguyen T, Oak J et al (2025) CIC-rearrangements in pediatric acute erythroid leukemia\/erythroblastic sarcoma. Pediatr Blood Cancer 72:e31848","journal-title":"Pediatr Blood Cancer"},{"key":"723_CR5","doi-asserted-by":"publisher","DOI":"10.1002\/2056-4538.70079","volume":"12","author":"A Jenei","year":"2026","unstructured":"Jenei A, Kajtar B, Laszlo T et al (2026) Frequent NPM1 mutation, monoblastic\/monocytic origin and prognostic significance of organ and system involvement in myeloid sarcoma: a multicenter study. J Pathol Clin Res 12:e70079","journal-title":"J Pathol Clin Res"},{"key":"723_CR6","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.30203","volume":"70","author":"F de Oliveira Mota","year":"2023","unstructured":"de Oliveira Mota F, Gamba FT, de Carvalho Pires MG et al (2023) NUP214::ABL1: a Ph-like fusion found in a pediatric acute myeloid leukemia patient with normal karyotype. Pediatr Blood Cancer 70:e30203","journal-title":"Pediatr Blood Cancer"},{"key":"723_CR7","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1038\/ng1425","volume":"36","author":"C Graux","year":"2004","unstructured":"Graux C, Cools J, Melotte C et al (2004) Fusion of NUP214 to ABL1 on amplified episomes in T-cell acute lymphoblastic leukemia. Nat Genet 36:1084\u20139","journal-title":"Nat Genet"},{"key":"723_CR8","doi-asserted-by":"publisher","first-page":"e397","DOI":"10.1097\/MPH.0000000000001007","volume":"40","author":"SI Tsujimoto","year":"2018","unstructured":"Tsujimoto SI, Nakano Y, Osumi T et al (2018) A cryptic NUP214-ABL1 fusion in B-cell precursor acute lymphoblastic leukemia. J Pediatr Hematol Oncol 40:e397\u2013e399","journal-title":"J Pediatr Hematol Oncol"},{"key":"723_CR9","doi-asserted-by":"publisher","first-page":"250","DOI":"10.14740\/jmc4286","volume":"15","author":"C Wakefield","year":"2024","unstructured":"Wakefield C, Hansen Smith M, Dashkevych U et al (2024) Clinical, phenotypic and molecular characterization of NUP214-ABL1 fusion positive myeloid malignancies. J Med Cases 15:250\u2013255","journal-title":"J Med Cases"},{"key":"723_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.706798","volume":"11","author":"HP Wang","year":"2021","unstructured":"Wang HP, He JJ, Zhu QY et al (2021) Case report: the first report of NUP214-ABL1 fusion gene in acute myeloid leukemia patient detected by next-generation sequencing. Front Oncol 11:706798","journal-title":"Front Oncol"},{"key":"723_CR11","doi-asserted-by":"publisher","first-page":"2832","DOI":"10.1080\/10428194.2019.1605510","volume":"60","author":"I Aldoss","year":"2019","unstructured":"Aldoss I, Pullarkat V (2019) Response to single agent dasatinib post allogeneic transplant in B-cell acute lymphoblastic leukemia with NUP214-ABL1. Leuk Lymphoma 60:2832\u20132834","journal-title":"Leuk Lymphoma"},{"key":"723_CR12","first-page":"3979","volume":"14","author":"Y Chen","year":"2017","unstructured":"Chen Y, Zhang L, Huang J et al (2017) Dasatinib and chemotherapy in a patient with early T-cell precursor acute lymphoblastic leukemia and NUP214-ABL1 fusion: a case report. Exp Ther Med 14:3979\u20133984","journal-title":"Exp Ther Med"},{"key":"723_CR13","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/leu.2008.318","volume":"23","author":"W Deenik","year":"2009","unstructured":"Deenik W, Beverloo HB, van der Poel-van de Luytgaarde SC et al (2009) Rapid complete cytogenetic remission after upfront dasatinib monotherapy in a patient with a NUP214-ABL1-positive T-cell acute lymphoblastic leukemia. Leukemia 23:627\u20139","journal-title":"Leukemia"},{"key":"723_CR14","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1038\/sj.leu.2403877","volume":"19","author":"K Stergianou","year":"2005","unstructured":"Stergianou K, Fox C, Russell NH (2005) Fusion of NUP214 to ABL1 on amplified episomes in T-ALL--implications for treatment. Leukemia 19:1680\u20131681","journal-title":"Leukemia"}],"container-title":["Journal of Hematopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12308-026-00723-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12308-026-00723-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12308-026-00723-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T08:47:32Z","timestamp":1787042852000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12308-026-00723-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,18]]},"references-count":14,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["723"],"URL":"https:\/\/doi.org\/10.1007\/s12308-026-00723-4","relation":{},"ISSN":["1865-5785"],"issn-type":[{"value":"1865-5785","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,18]]},"assertion":[{"value":"13 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. IRB approval is not required for this type of study.","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"For this type of study, informed consent is not required.","order":2,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"For this type of study, consent for publication is not required.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"48"}}